Ph-Ch26:Packaging

Packaging involves the process of packing loose second-line anti-TB drugs into one-monthly Patient-wise Boxes (PWBs) also known as the standardised drug boxes for shorter, longer Multidrug/ Rifampicin-resistant TB (MDR/RR-TB) and for H-mono/ poly Drug-resistant TB (DR-TB) regimen.

• The drug box preparation is preferably done at the State Drug Store (SDS) level. However, in states that have built the capacity of districts, the exercise of preparation of standard PWBs may also be conducted at District Drug Stores (DDS) under the guidance and supervision of the District TB Officer (DTO).
• The DDS is supplied monthly PWBs as per the standard regimens as well as loose medicines for replacement.
• Under certain circumstances, the drug box may also be prepared at the district level, like unpacking of unused/ partially used boxes and modification of regimen as per replacement advised by the DR-TB centre.

Resources

• Guidelines for Programmatic Management of Drug-resistant Tuberculosis in India, NTEP, Central TB Division, Ministry of Health and Family Welfare, Government of India, 2021.
• Standard Operating Procedure Manual Procurement & Supply Chain Management, Central TB Division, Ministry of Health and Family Welfare, Government of India. 

Assessment

In the National Tuberculosis Elimination Programme (NTEP), packaging of loose drugs into Type A, B & C boxes are done at the State Drug Stores (SDSs) under the guidance of the State TB Officer (STO)/ Medical Officer (MO)/ Drug logistics in-charge.

Specifications for packaging of patient-wise monthly drug box

Common for both Type A and Type B boxes

• Material: Punching ring flap model (1 side pin) 3 ply corrugated, top paper 230 gsm, ply 150 gsm and the inner wall of 180 gsm.
• Opening: From the top with the attached lid.
• Packing: Box should be stapled with heavy pins.
• Colour: Outer white and inner brown

Type A Box

• Size: 10.5” x 7.5” x 3.25”  (inch)
• Partitions in the box: 3 ply white to white vertical and 12 horizontal, fitting in to vertical serially
• Size of partition: Horizontal: 7.5” x 2.75” – Vertical 10” x 2.75”
• In each Type A box, one pouch of silica gel desiccant of 4 gm weight should be kept.
• One monthly pouch of capsule Cycloserine and tablet Ethambutol each should be made from a plastic bag with a zip lock facility in which a 1 gm pouch of silica gel desiccant should be kept.

Type B box

• Size: 11” x 4” x 4”  (inch)

Figure 1: Type A Box; Source: Guidelines on Programmatic Management of Drug-resistant TB (PMDT) in India; CTD, MoHFW, India, 2017.

Figure 2: Type B Box; Source: Guidelines on Programmatic Management of Drug-resistant TB (PMDT) in India; CTD, MoHFW, India, 2017.

Specifications for Labelling of Patient-wise Monthly Drug Box

• Once the patient-wise monthly drug box is prepared, labels for these drug boxes should also be prepared to contain all details about the drugs within the box and printed directly from the Ni-kshay Aushadhi system.
• Labels should be generated for each cycle of box preparation and contain expiry-wise drug content of the boxes and should be pasted over the boxes prepared during that cycle only.
• The label should be marked with a bold marker pen and pasted on the visible side of the carton.
• Labelling the drug boxes helps in facilitating the storekeeper to follow the First Expiry First Out (FEFO) principle, avoids excessive stocking of shortage drugs/ drug stock imbalances, enables issue of the regimen-wise box systematically and the barcode present on the label helps to ensure better inventory, tracking and supply chain management.

Resources

• Guidelines on Programmatic Management of Drug-resistant TB (PMDT) in India; CTD, MoHFW, India, 2017.
• Standard Operating Procedure Manual Procurement & Supply Chain Management; CTD, MoHFW,India,2018.
• Procurement, Supply Chain Management & Preventive Maintenance, Module 6; CTD, MoHFW, India.

Assessment

Importance of Labelling the Drug Boxes

• It helps to identify regimen-wise boxes quickly
• It helps the storekeeper in practising the First Expiry First Out (FEFO) principle
• Ensures better inventory management
• Strengthens the tracking and supply chain through the bar code present on the label

Contents of the label

Figure 1: Drug Box label; Source: Packaging and Repackaging,Nikshay Aushadhi User Manual; CTD, MoHFW, India.

Method of Labelling the Drug Boxes

Figure 2:Label pasted on the drug box

• The labels should be pasted on the visible side of the carton.
• The label should be in bold colours for quick identification.
• There should be different coloured labels for different regimens as well as for the intensive and continuation phases.
• The label should be pasted in an oblong manner on the box to allow quick readability.
• The label should be generated through the Ni-kshay Aushadhi during each cycle of box preparation and printed directly from the system.
• The labels prepared for a particular cycle should be pasted over the boxes prepared during that cycle only.

Resources

• Standard Operating Procedure Manual Procurement & Supply Chain Management; CTD, MoHFW,India,2018.
• Procurement, Supply Chain Management & Preventive Maintenance, Module 6; CTD, MoHFW, India.
• Packaging and Repackaging,Nikshay Aushadhi User Manual; CTD, MoHFW, India.

Assessment

There are two types of monthly Patient Wise Boxes (PWB) issued to the TB patients.

1) Type A: Contains oral drugs that are used for treatment during both the Intensive Phase (IP) and Continuation Phase (CP).

2) Type B: Contains injectables which are prescribed for Intensive Phase (IP) only

Based on the regimen and weight band of the patients , PWB are prepared and issued to the patients.

Contents of PWB

1. PWB for Shorter Oral Bedaquiline-containing MDR/RR-TB Regimen: Constitutes both Type A and Type B box

* When moxifloxacin is prescribed under exceptional conditions instead of levofloxacin, the modified box with moxifloxacin (normal dose) can be prepared from the standard box at DDS.

2. PWB for Shorter Injectable-containing Regimen: Constitutes both Type A and Type B box

3. PWB for Longer Oral M/XDR-TB Regimen : Constitutes only Type A box as there is no separate IP/CP under this regimen

# Tab. Linezolid available in 600 mg only. When prescribed with modified dose of 300 mg Once Daily (OD), patient should be advised to divide the pill in half.

4.  PWB for H-mono/poly DR-TB Regimen: Constitutes only Type A box as there is no separate IP/CP under this regimen

In comparison to other DR-TB regimens, a full treatment course should be prepared for the entire duration of 6 months.

Resources

• Standard Operating Procedure Manual Procurement & Supply Chain Management, CTD, MoHFW,India,2018
• Procurement, Supply Chain Management & Preventive Maintenance, Module 6, CTD, MoHFW, India.

Assessment